Sexual health and melanocortin - PeptideBlog

Sexual health and melanocortin

Research area

Sexual health and melanocortin

Compounds studied for effects on sexual function through melanocortin-receptor and related pathways.

9 entries in this category.

  • Gonadorelin

    Gonadorelin is FDA-approved synthetic GnRH, historically used for diagnostic pituitary testing and, via a dedicated pulsatile pump, to induce ovulation. Its now-common off-label use in TRT protocols, injected two to three times weekly, does not reproduce the roughly hourly pulse its mechanism depends on and lacks a dedicated trial.

  • HCG

    HCG is an FDA-approved glycoprotein hormone used, in the context relevant to this site, as an injectable adjunct to testosterone replacement therapy and for male hypogonadotropic hypogonadism, mimicking LH to keep the testes active. It has genuine approved indications with labeled doses, and a separate, widely practiced but off-label TRT-adjacent fertility-preservation use with practitioner- and community-reported dosing.

  • Kisspeptin-10

    Kisspeptin-10 is the short bioactive fragment of an endogenous reproductive hormone. Real human trials exist for this hormone family, including a Phase 2 IVF trigger trial with a 95% oocyte maturation rate, but almost all of the substantial trial work used the longer-acting kisspeptin-54, not kisspeptin-10 specifically.

  • KPV

    Also relevant to sexual health and melanocortin research. KPV is a three amino acid fragment of alpha-MSH with anti-inflammatory activity in cell culture and in mice. No human trial of it has ever been published or registered, and the FDA said the same in its own 2026 review.

    * Also filed under: Tissue repair and recovery

  • Melanotan 1

    Melanotan 1 (afamelanotide) is FDA- and EMA-approved as Scenesse, a 16 mg implant given once every 60 days for erythropoietic protoporphyria, not for tanning. Tanning and libido effects are real but are not what the drug is approved or tested for as a primary outcome.

  • Melanotan 2

    Melanotan II was never approved and has never completed a human trial for tanning or libido; it is the unmodified parent compound of two drugs (afamelanotide, bremelanotide) that were each derived from it specifically to remove one of its side effects. Case reports document priapism and concerning changes to existing moles.

  • Oxytocin

    Oxytocin is FDA-approved as an IV/IM obstetric drug (Pitocin) for labor and postpartum bleeding, a completely different use from the unapproved intranasal form studied for social cognition and psychiatric conditions. A 2026 meta-analysis of 42 RCTs found an overall effect close to zero for that intranasal use.

  • PT-141

    PT-141 (bremelanotide) is FDA-approved as Vyleesi, an on-demand 1.75 mg subcutaneous injection for hypoactive sexual desire disorder in premenopausal women. It has no approval and no published Phase 3 trial for use in men, despite circulating that way.

  • Triptorelin

    Triptorelin is an FDA-approved GnRH agonist (Trelstar, Decapeptyl, Triptodur) used to suppress sex hormone production for prostate cancer and central precocious puberty, with decades of Phase 3 evidence. Its approved mechanism is hormone suppression, not optimization, and it has no approved or trial-supported general wellness use.